Zobrazeno 1 - 10
of 1 040
pro vyhledávání: '"Satoshi, Takeuchi"'
Autor:
Hao Zhang, Takahiro Tsuchikawa, Satoshi Takeuchi, Hang Deng, Kimitaka Tanaka, Aya Matsui, Yoshitsugu Nakanishi, Toshimichi Asano, Takehiro Noji, Toru Nakamura, Shintaro Takeuchi, Masataka Wada, Jian Xu, Yu Zhang, Satoshi Hirano
Publikováno v:
World Journal of Surgical Oncology, Vol 22, Iss 1, Pp 1-9 (2024)
Abstract Introduction Survival comparisons among patients with liver metastases from pancreatic and rectal neuroendocrine tumors (NETs) were limited, and the efficacy of observation rules in patients undergoing hepatectomy for neuroendocrine liver me
Externí odkaz:
https://doaj.org/article/ae340f10346a468781e18f0819da9489
Autor:
Satoshi Takeuchi, Satoshi Honda, Kensaku Nishihira, Sunao Kojima, Misa Takegami, Yasuhide Asaumi, Mike Saji, Jun Yamashita, Kiyoshi Hibi, Jun Takahashi, Yasuhiko Sakata, Morimasa Takayama, Tetsuya Sumiyoshi, Hisao Ogawa, Kazuo Kimura, Satoshi Yasuda, JAMIR Investigators
Publikováno v:
ESC Heart Failure, Vol 11, Iss 4, Pp 2344-2353 (2024)
Abstract Aims The incidence and prognosis of symptomatic heart failure following acute myocardial infarction (AMI) in the primary percutaneous coronary intervention era have rarely been reported in the literature. This study aimed to (i) determine th
Externí odkaz:
https://doaj.org/article/a413c3f7ce1b4b9c8ec55aff0ee3425e
Autor:
Hao Zhang, Takahiro Tsuchikawa, Satoshi Takeuchi, Kenji Hirata, Kimitaka Tanaka, Aya Matsui, Yoshitsugu Nakanishi, Toshimichi Asano, Takehiro Noji, Toru Nakamura, Shintaro Takeuchi, Masataka Wada, Satoshi Hirano
Publikováno v:
Endocrine Journal, Vol 71, Iss 9, Pp 873-880 (2024)
As novel biomarkers for gastroenteropancreatic neuroendocrine tumors (GEPNET) are in demand, we aimed to validate the clinical value of the NETest in Japanese patients. Between 2021 and 2023, blood and clinical data were collected from patients with
Externí odkaz:
https://doaj.org/article/39465c1aa9dc4078afadaefabe35b0aa
Autor:
Satoshi Takeuchi, Kenji Hirata, Keiichi Magota, Shiro Watanabe, Rika Moku, Akihiko Shiiya, Jun Taguchi, Shin Ariga, Tomohiro Goda, Yoshihito Ohhara, Takurou Noguchi, Yasushi Shimizu, Ichiro Kinoshita, Rio Honma, Yasushi Tsuji, Akihiro Homma, Hirotoshi Dosaka-Akita
Publikováno v:
EJNMMI Research, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract Background Lenvatinib is widely used to treat unresectable and advanced thyroid carcinomas. We aimed to determine whether 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) performed 1 week after lenvatini
Externí odkaz:
https://doaj.org/article/819bc9878b544a5a980134ac2b93bddd
Autor:
Yuma Hane, Takahiro Tsuchikawa, Kimitaka Tanaka, Yoshitsugu Nakanishi, Toshimichi Asano, Takehiro Noji, Yo Kurashima, Yuma Ebihara, Soichi Murakami, Toru Nakamura, Keisuke Okamura, Satoshi Takeuchi, Toshiaki Shichinohe, Satoshi Hirano
Publikováno v:
Surgical Case Reports, Vol 6, Iss 1, Pp 1-5 (2020)
Abstract Background Rectal neuroendocrine neoplasms (NENs) are rare, but their incidence has increased in recent years. The metastasis rate is low in cases of a tumor diameter
Externí odkaz:
https://doaj.org/article/be8465f784d74a368d0307d2f769405a
Publikováno v:
The Journal of Physical Chemistry Letters. 14:2845-2853
Autor:
Akihiko Shiiya, Takuro Noguchi, Utano Tomaru, Shin Ariga, Yuta Takashima, Yoshihito Ohhara, Jun Taguchi, Satoshi Takeuchi, Yasushi Shimizu, Ichiro Kinoshita, Tomonobu Koizumi, Yoshihiro Matsuno, Naofumi Shinagawa, Jun Sakakibara‐Konishi, Hirotoshi Dosaka‐Akita
Publikováno v:
Cancer Science. 114:1270-1283
Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) elicit potent cell cycle arrest in EGFR-mutant non-small-cell lung cancer (NSCLC) cells. However, little is known about the mechanisms through which these drugs alter the tumor
Autor:
Satoshi Takeuchi, Masahiro Kagabu, Tadahiro Shoji, Yukari Nitta, Toru Sugiyama, Junya Sato, Yusuke Nakamura
Publikováno v:
OncoImmunology, Vol 9, Iss 1 (2020)
We had conducted phase 1/2 studies of cancer vaccination therapy using neo-tumor antigens in patients with refractory/persistent cervical cancer (CC) and ovarian cancer (OC) to assess the feasibility and efficacy. Enrollees must be refractory/persist
Externí odkaz:
https://doaj.org/article/e6c3f39f6e5d435593a55f65e7673ead
Autor:
Kenjiro Hanaoka, Shimpei Iwaki, Kiyoshi Yagi, Takuya Myochin, Takayuki Ikeno, Hisashi Ohno, Eita Sasaki, Toru Komatsu, Tasuku Ueno, Motokazu Uchigashima, Takayasu Mikuni, Kazuki Tainaka, Shinya Tahara, Satoshi Takeuchi, Tahei Tahara, Masanobu Uchiyama, Tetsuo Nagano, Yasuteru Urano
Publikováno v:
Journal of the American Chemical Society. 144:19778-19790
Fluorogenic probes for bioimaging have become essential tools for life science and medicine, and the key to their development is a precise understanding of the mechanisms available for fluorescence off/on control, such as photoinduced electron transf
Autor:
Norihiro Aiga, Satoshi Takeuchi
Publikováno v:
The Journal of Physical Chemistry C. 126:16227-16235